I-Shu Chen
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
- Healthcare and Venom Research
Papers in
-
- Ion channel regulation and function 9
- Pharmacological Receptor Mechanisms and Effects 4
- Protein Kinase Regulation and GTPase Signaling 2
- Surgery 9
- Thyroid and Parathyroid Surgery 3
- Co-authors
- Yi‐Chen Chen (3 shared papers)Shiuh‐Inn Liu (17 shared papers)Chih‐Hsien Chiu (2 shared papers)Yu‐Chia Chen (9 shared papers)Chung‐Ren Jan (17 shared papers)Cheng‐Chung Tsai (9 shared papers)Being‐Whey Wang (8 shared papers)Chung‐Hsi Chou (1 shared paper)
In The Last Decade
I-Shu Chen
43 papers receiving 883 citations
Peers
Comparison fields: 5 of 90
- Hepatology 210
- Pharmacology 101
- Molecular Medicine 46
- Pharmacology 106
- Gastroenterology 28
Countries citing papers authored by I-Shu Chen
This map shows the geographic impact of I-Shu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I-Shu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I-Shu Chen more than expected).
Fields of papers citing papers by I-Shu Chen
This network shows the impact of papers produced by I-Shu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I-Shu Chen. The network helps show where I-Shu Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside I-Shu Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 105 | |
| 2 | 2012 | 100 | |
| 3 | 2011 | 70 | |
| 4 | 2006 | 69 | |
| 5 | 2003 | 67 | |
| 6 | 2011 | 56 | |
| 7 | 2006 | 46 | |
| 8 | 2017 | 34 | |
| 9 | 2017 | 31 | |
| 10 | 2017 | 29 | |
| 11 | 2008 | 28 | |
| 12 | 2011 | 24 | |
| 13 | 2012 | 24 | |
| 14 | 1998 | 22 | |
| 15 | 2019 | 21 | |
| 16 | 2006 | 14 | |
| 17 | 2011 | 12 | |
| 18 | 2016 | 12 | |
| 19 | 2016 | 12 | |
| 20 | Effects of antrodia camphorata on viability, apoptosis, and [Ca2+]i in PC3 human prostate cancer cells. | 2008 | 12 |
About I-Shu Chen
I-Shu Chen is a scholar working on Molecular Biology, Surgery, Hepatology, Cellular and Molecular Neuroscience and Pharmacology, having authored 45 papers that have together received 902 indexed citations. Recurring topics across this work include Ion channel regulation and function (9 papers), Neuroscience and Neuropharmacology Research (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Pharmacological Receptor Mechanisms and Effects (4 papers), Thyroid and Parathyroid Surgery (3 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Ion Channels and Receptors (2 papers). The work is most often cited by research in Hepatology (210 citations), Pharmacology (101 citations), Molecular Medicine (46 citations), Pharmacology (106 citations) and Gastroenterology (28 citations). I-Shu Chen has collaborated with scholars based in Taiwan, Israel and China. Frequent co-authors include Yi‐Chen Chen, Shiuh‐Inn Liu, Chih‐Hsien Chiu, Yu‐Chia Chen, Chung‐Ren Jan, Cheng‐Chung Tsai, Being‐Whey Wang, Chung‐Hsi Chou, Lee‐Yan Sheen and Shu‐Chen Hsieh. Their work appears in journals such as Journal of Personalized Medicine, European Journal of Pharmacology, Journal of the American College of Surgeons, Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.